|
Press Releases |
|
 |
|
Thursday, August 1, 2019 |
|
Eisai to Refresh and Launch Sahne Cream After 20 Years with Mild Scent and New Package |
Eisai Co., Ltd. announced today that it refresh its SAHNE CREAM (quasi-drug) which has been widely used as medical skin care, for the first time in 20 years, and launch at pharmacies and drug stores in Japan on today August 1, 2019. more info >> |
|
Tuesday, July 23, 2019 |
|
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Breakthrough Therapy Designation from FDA |
This is the third Breakthrough Therapy designation for the LENVIMA plus KEYTRUDA combination. more info >> |
|
Friday, July 19, 2019 |
|
Eisai Presented Latest Trends of Treatment for Alzheimer's at AAIC 2019 |
Eisai Co.,Ltd. announced the presentation and discussion about the treatment, including oral beta amyloid cleaving enzyme (BACE) inhibitor elenbecestat research data on Alzheimer's disease(AD). more info >> |
|
Eisai Presented Data Showing Quantification of Tau Microtubule Binding Region at AAIC 2019 |
Eisai Co.,Ltd. announced that data relating to a new anti-tau antibody E2814(1) was presented at the Alzheimer's Association International Conference (AAIC) held in Los Angeles, California, United States, from July 14 to 18, 2019 (Poster Presentation No.: P4-696). more info >> |
|
Thursday, July 18, 2019 |
|
Eisai Presents Research Evaluating Correlation of Highly-Precisely Measured Amyloid Beta in Plasma and Cerebrospinal Fluid with Newly Developed Automated Protein Assay System at AAIC 2019 |
Eisai Co.,Ltd. announced its latest research on evaluation about correlation of amyloid beta (Abeta) in plasma and in cerebrospinal fluid (CSF) by high precision measurement with the newly developed automated protein assay system, jointly developed with Sysmex Corporation. more info >> |
|
Eisai Presents Nonclinical Research Results of Elenbecestat at AAIC 2019 |
Eisai Co.,Ltd. announced its latest data of nonclinical research which examined the effect to the synaptic function in the brain by spinal densities in regard to oral BACE (beta-site amyloid precursor protein cleaving enzyme) inhibitor elenbecestat were presented at AAIC. more info >> |
|
Wednesday, July 17, 2019 |
|
Eisai's Anticancer Agent Halaven Approved for Treatment of Locally Advanced or Metastatic Breast Cancer in China |
Eisai has received a New Drug Approval for its in-house developed anticancer agent Halaven (eribulin mesylate) for use in the treatment of patients with locally advanced or metastatic breast cancer, previously treated with at least two prior chemotherapy regimens, including an anthracycline and a taxane, from the China National Medical Products Administration (NMPA). more info >> |
|
Thursday, July 11, 2019 |
|
Eisai Listed for 18th Consecutive Year in FTSE4Good Index Series |
Eisai Co., Ltd. announced today that it has been included in the FTSE4Good Index Series for the 18th consecutive year since its initial inclusion in 2002. more info >> |
|
Latest Data on Eisai's Alzheimer's Disease/ Dementia Pipeline to be Presented at AAIC 2019 |
Eisai Co., Ltd. announced today that a total of 13 presentations containing two oral presentations including the latest data of the anti-amyloid beta (A beta) protofibril antibody BAN2401 and the oral BACE (beta amyloid cleaving enzyme) inhibitor elenbecestat, will be given at the Alzheimer's Association International Conference (AAIC) 2019.. more info >> |
|
Wednesday, July 10, 2019 |
|
Eisai Center for Genetics Guided Dementia Discovery Commences Full-Scale Operation Toward Innovative Dementia Treatments With New Drug Discovery Approach in Cambridge, Massachusetts |
Eisai Co., Ltd. has announced that the Eisai Center for Genetics Guided Dementia Discovery (G2D2), a new exploratory research facility in Cambridge, Massachusetts, U.S., held its opening ceremony and has begun full-scale research activities. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Seven HKTDC mega events showcase Asia's creative hub
Apr 11, 2025 16:30 HKT/SGT
|
|
|
Smart Lighting Expo and Spring Lighting Fair attracts some 15,000 global buyers
Apr 11, 2025 15:24 HKT/SGT
|
|
|
Transform Your Social Media Profile into a Sales Catalog with GoDaddy's Show in Bio Tool
Apr 11, 2025 15:06 HKT/SGT
|
|
|
3rd ASEAN Procurement Innovation Summit & Awards 2025 - The Next Frontier in Procurement Excellence
Apr 11, 2025 14:56 HKT/SGT
|
|
|
Mitsubishi Motors Begins Shipping Xforce HEV Model in Thailand
Apr 11, 2025 15:03 JST
|
|
|
Collaboration to Make Engine-Equipped Vehicles Carbon Neutral Using Synthetic Fuel
Apr 11, 2025 14:03 JST
|
|
|
TGR to Launch Evolved GR Yaris
Apr 11, 2025 13:35 JST
|
|
|
Sunshine Insurance: Practicing 'Insurance for the People'
Apr 11, 2025 12:20 HKT/SGT
|
|
|
AEON CREDIT SERVICE (ASIA) COMPANY LIMITED FY2024/25 Revenue Up to HK$1,759.3 million with Net Profit of HK$400.5 million
Apr 11, 2025 12:19 HKT/SGT
|
|
|
Fujitsu develops employee training platform for Seven-Eleven Japan to accelerate store digitalization
Apr 11, 2025 11:29 JST
|
|
|
Mitsubishi Corporation makes DennoKotsu an equity-method affiliate company, strengthening efforts to address regional transportation challenges
Apr 11, 2025 10:39 JST
|
|
|
JCB Enhances Customer Experience with Expanded Payment Acceptance for App Store and Apple Services in Asia
Apr 11, 2025 10:00 JST
|
|
|
Fujitsu and Headwaters trial on-device generative AI solution to streamline JAL cabin crew workflows
Apr 11, 2025 9:07 JST
|
|
|
Global strategic speakers confirmed to accelerate energy transformation at Japan Energy Summit & Exhibition 2025
Apr 11, 2025 08:03 HKT/SGT
|
|
|
Trading Nations Global Releases Transformative White Paper Empowering a Quantum-Resilient Future Through Collaboration
Apr 11, 2025 07:30 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|